The Medical Legal Environment in Neurosurgery: An Informative Overview of the Stages of Litigation and Distinct Challenges.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
07 2021
Historique:
received: 19 01 2021
revised: 05 03 2021
accepted: 06 03 2021
entrez: 10 7 2021
pubmed: 11 7 2021
medline: 10 9 2021
Statut: ppublish

Résumé

Medical malpractice litigation is something that every neurosurgeon encounters in his or her career and causes significant strife to amateur physicians attempting to navigate the medicolegal process. Neurosurgery in particular is one of the highest risk specialties for litigation. This calls to order the importance of a clear understanding of the medicolegal proceedings that may follow after a complaint has been filed. This report describes the steps to be taken by the physician in the instance that litigation is expected or considered a possibility. We describe the elements that comprise a medical malpractice claim, details of the lawsuit process including hospital peer review and expert witness selection, and how to communicate appropriately with the patients and their families in an empathetic way. It is imperative to gain an appropriate understanding of the entirety of the malpractice claim process to ease the anxiety of litigation for the physician and decrease the amount of avoidable complications.

Identifiants

pubmed: 34243671
pii: S1878-8750(21)00407-1
doi: 10.1016/j.wneu.2021.03.039
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

370-374

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Devon Lefever (D)

Department of Neurosurgery, LSU Health Sciences Center, Shreveport, Louisiana, USA.

Darian R Esfahani (DR)

Department of Neurosurgery, University of Illinois Hospital and Health Sciences System, Chicago, Illinois, USA.

Sandeep Kandregula (S)

Department of Neurosurgery, LSU Health Sciences Center, Shreveport, Louisiana, USA.

Krystle Trosclair (K)

Department of Neurosurgery, LSU Health Sciences Center, Shreveport, Louisiana, USA.

Audrey Demand (A)

Department of Neurosurgery, LSU Health Sciences Center, Shreveport, Louisiana, USA.

Alexis Vega (A)

Department of Neurosurgery, LSU Health Sciences Center, Shreveport, Louisiana, USA.

Jason Stacy (J)

North Mississippi Neurosurgical Services, North Mississippi Medical Center, Tulepo, Mississippi, USA.

Namath Hussein (N)

Department of Neurosurgery, Loma Linda University Medical Center, Loma Linda, USA.

Rimal Dossani (R)

Department of Neurosurgery, University at Buffalo, Buffalo, USA.

Arjun Pendharkar (A)

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.

Richard Menger (R)

Department of Neurosurgery, Department of Political Science, University of South Alabama, Mobile, Alabama, USA.

Jennifer Kosty (J)

Department of Neurosurgery, LSU Health Sciences Center, Shreveport, Louisiana, USA.

Catherine Mazzola (C)

Division of Pediatric Neurological Surgery, Goryeb Children's Hospital, Morristown, New Jersey, USA.

Nitin Agarwal (N)

Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Kristopher Kimmell (K)

Department of Neurosurgery, University of Rochester Medical Center, Rochester, New York, USA.

Joshua Rosenow (J)

Department of Anesthesiology, Division of Pain Medicine and Department of Neurosurgery, Northwestern University Medical Center, Chicago, Illinois, USA.

Jeffrey Cozzens (J)

Neuroscience Institute, Southern Illinois University School of Medicine, Springfield, Illinois, USA.

Clemens Schirmer (C)

Department of Neurosurgery and Neuroscience Institute, Geisinger Health System, Wilkes-Barre, USA.

Bharat Guthikonda (B)

Department of Neurosurgery, LSU Health Sciences Center, Shreveport, Louisiana, USA. Electronic address: bguthi@lsuhsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH